Patents by Inventor Bobby E. Rogers
Bobby E. Rogers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12383174Abstract: A fluid sample optimization device for optimizing a fluid sample includes an inlet, an outlet, a sample path connected between the inlet and the outlet, and a contaminant containment reservoir connected between the inlet and the outlet. The contaminant containment reservoir includes an air permeable fluid resistor proximate the outlet, and is arranged to receive, when a pressure differential is applied between the inlet and the outlet, a first portion of the fluid sample to displace air therein through the air permeable fluid resistor and the outlet, such that upon receipt of the first portion of the fluid sample and containment of the contaminants in the contaminant containment reservoir, subsequent portions of the fluid sample can be conveyed by the sample path from the inlet to the outlet when subsequent pressure differentials are applied between the inlet and the outlet.Type: GrantFiled: April 1, 2020Date of Patent: August 12, 2025Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Kevin Nason, David Karl Stroup, David G. Matsuura, Belinko K. Matsuura
-
Patent number: 12357209Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: October 25, 2023Date of Patent: July 15, 2025Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Patent number: 12257051Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: May 15, 2023Date of Patent: March 25, 2025Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski
-
Publication number: 20250049362Abstract: A bodily fluid collection system for collecting a bodily fluid from a patient, and a bodily fluid transfer system for transferring collected bodily fluid to a second collection device. A collection adapter has a connection port configured to securely connect with a hub of a syringe, and a collection interface opposite the connection port creates a fluid conduit to the barrel via the connection port and an inlet of the hub. A proximal adapter is connected to a proximal end of the fluid channel from the patient, and configured to removably interact with the collection interface of the collection adapter to connect the proximal end of the fluid channel to the barrel via the fluid conduit and inlet to the barrel to allow conveyance into the barrel of the at least some of the sampling portion of the sample of bodily fluid. The proximal adapter can be removed to allow access to any bodily fluid collected by the syringe.Type: ApplicationFiled: September 11, 2024Publication date: February 13, 2025Applicant: Kurin, Inc.Inventors: Thomas Thompson, Kevin Nason, Bobby E. Rogers, Jeffrey VELOZ
-
Publication number: 20250025079Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: September 26, 2024Publication date: January 23, 2025Applicant: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Patent number: 12138052Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: July 24, 2024Date of Patent: November 12, 2024Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Publication number: 20240198005Abstract: Disclosed are systems that include a syringe having a barrel configured to hold a fluid and a plunger configured to draw the fluid into the barrel when the plunger is pulled backward through the barrel. The syringe is configured to inhibit forward movement of the plunger. For example, the systems can include mating pockets configured to engage barbs to inhibit forward movement of the plunger.Type: ApplicationFiled: March 5, 2024Publication date: June 20, 2024Applicant: Kurin, Inc.Inventors: Kevin Nason, Jeffrey Veloz, Bobby E. Rogers, Nolan Pupping
-
Patent number: 11963769Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: November 30, 2021Date of Patent: April 23, 2024Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Patent number: 11832944Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: February 24, 2023Date of Patent: December 5, 2023Assignee: KURIN, INC.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Patent number: 11826527Abstract: A safety needle assembly includes a housing and a cannula hub connected within a side wall of the housing, a needle connected to the cannula and extending from the cannula hub outward from a proximal end of the housing, and a spring connected with the housing. The assembly includes a barrel connected with the spring and at least partially contained within the housing to least partially cover the cannula hub. The barrel is configured for moving, sliding, traveling, activating, relocating, or transitioning from a first mode in which the barrel is securely retracted and locked at least partially within the housing and the needle extends through an aperture of the barrel and the proximal end of the housing, to a second mode in which the barrel extends from the proximal end and beyond the needle.Type: GrantFiled: July 25, 2018Date of Patent: November 28, 2023Assignee: KURIN, INC.Inventors: Bobby E. Rogers, David Karl Stroup
-
Patent number: 11744494Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: November 10, 2020Date of Patent: September 5, 2023Assignee: KURIN, INC.Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski
-
Patent number: 11617525Abstract: A blood sequestration device includes an inlet path, an outlet path, a sequestration chamber, and a sampling channel. The sequestration chamber is connected with the inlet path by a junction and is configured to receive a first portion of blood through the inlet path. The sequestration chamber has a vent that allows air to be displaced by the first portion of blood, the junction being configured to inhibit a return to the inlet path of any of the first portion of blood received by the sequestration chamber. The sampling channel is connected between the inlet path and the outlet path, and configured to convey subsequent amounts of blood between the inlet path and the outlet path after the first amount of blood is received by the sequestration chamber.Type: GrantFiled: March 13, 2020Date of Patent: April 4, 2023Assignee: KURIN, INC.Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski, Kevin Nason
-
Publication number: 20220330858Abstract: A bodily fluid collection system for collecting a bodily fluid from a patient, and a bodily fluid transfer system for transferring collected bodily fluid to a second collection device. A collection adapter has a connection port configured to securely connect with a hub of a syringe, and a collection interface opposite the connection port creates a fluid conduit to the barrel via the connection port and an inlet of the hub. A proximal adapter is connected to a proximal end of the fluid channel from the patient, and configured to removably interact with the collection interface of the collection adapter to connect the proximal end of the fluid channel to the barrel via the fluid conduit and inlet to the barrel to allow conveyance into the barrel of the at least some of the sampling portion of the sample of bodily fluid. The proximal adapter can be removed to allow access to any bodily fluid collected by the syringe.Type: ApplicationFiled: March 17, 2022Publication date: October 20, 2022Inventors: Thomas Thompson, Kevin Nason, Bobby E. Rogers, Jeffrey VELOZ
-
Patent number: 11311219Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: December 27, 2017Date of Patent: April 26, 2022Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski
-
Patent number: 11185266Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: December 4, 2018Date of Patent: November 30, 2021Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Patent number: 10827964Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: February 9, 2018Date of Patent: November 10, 2020Assignee: Kurin, Inc.Inventors: Bobby E. Rogers, Gino Kang, David Karl Stroup, Jonas Dean Cochran, Arthur Deptala, John Detloff, Lonnie Pogue, Brian Macowski, Chad Garrett
-
Publication number: 20190159711Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: December 4, 2018Publication date: May 30, 2019Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Patent number: 10195000Abstract: A cleaning device for a medical implement such as a female Luer connector. The cleaning device includes a cap having an interior cavity and an opening adapted to receive a site of the medical implement. The interior cavity is defined by an interior wall that includes a male Luer protrusion extending in the direction of the opening from an end of the interior cavity opposite the opening. A skin of cleaning material overlies at least a portion of the interior wall. The cleaning material may be pre-loaded with a cleaning agent and is adapted to clean the site of the medical implement.Type: GrantFiled: February 8, 2017Date of Patent: February 5, 2019Assignee: 3M Innovative Properties CompanyInventors: Bobby E. Rogers, Gino Kang
-
Patent number: 10143412Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: GrantFiled: May 31, 2018Date of Patent: December 4, 2018Assignee: KURIN, INC.Inventors: Bobby E. Rogers, Gino Kang, John Detloff
-
Publication number: 20180289304Abstract: Blood sample optimization systems and methods are described that reduce or eliminate contaminates in collected blood samples, which in turn reduces or eliminates false positive readings in blood cultures or other testing of collected blood samples. A blood sample optimization system can include a blood sequestration device located between a patient needle and a sample needle. The blood sequestration device can include a sequestration chamber for sequestering an initial, potentially contaminated aliquot of blood, and may further include a sampling channel that bypasses the sequestration chamber to convey likely uncontaminated blood between the patient needle and the sample needle after the initial aliquot of blood is sequestered in the sequestration chamber.Type: ApplicationFiled: May 31, 2018Publication date: October 11, 2018Applicant: KURIN, INC.Inventors: Bobby E. Rogers, Gino Kang, John Detloff